Stent with embolic protection device benefits high-risk patients

01/17/2012 | DailyRx.com

Stenting in combination with an embolic protection device resulted in lower complication rates for high-risk carotid artery disease patients, according to a University of Wisconsin clinical trial. The study was meant to evaluate Emboshield Pro, a device used with stenting to open blocked vessels and capture dislodged plaque. "This is very good news for high-risk patients suffering with carotid artery disease, who only a decade ago had limited treatment options and poor long-term outcomes," said Dr. Jon Matsumura, the lead researcher.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN